MedPath
NMPA Approval

Lacosamide Injection

国药准字HJ20190060

November 7, 2024

H20190060

Drug Information

拉考沙胺注射液

维派特

注射剂

20ml:0.2g

化学药品

November 7, 2024

November 6, 2029

Company Information

Applicant Company

UCB PHARMA SA

Allée de la Recherche 60, B-1070 Brussels, Belgium

Manufacturing Company

UCB-Pharma SA

Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

拉考沙胺注射液 - NMPA 批准文号 | MedPath